Skip to NavigationSkip to content

News

Pharmaceutical companies should be allowed to set their own prices in all the European Union countries in order to bring a single market one step...
Final breakthrough on England's consultant contract
Pfizer could be facing a backlash from PCTs angered by the recent price rise on two of its leading products, Istin and Celebrex.
UK biotech company Cambridge Antibody Technology says it remains on target to reach profitability by 2008 despite a doubling of its operating losses...
Xenova has halted phase III clinical trials of its lead product after an independent safety committee confirmed safety fears about the drug.
The crisis surrounding the proposed new GP contract has deepened after doctors refused to be tampededinto accepting a new contract, which many say...
Fred Hassan has announced a major re-organisation of Schering-Plough pharmaceutical operations just 17 days after taking on the job of turning around...
AstraZeneca has received a boost with the release of two positive studies for its new blood-thinning drug Exanta despite questions remaining over its...
One of the UK leading cancer hospitals will be forced to restrict access to treatment because of a shortage of funds.
The agreement between the UK government and the pharmaceutical industry which controls company profits is to be reviewed.